Latest News about Biotech
Recent news which mentions Biotech
Mental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical Data
July 25, 2024
From Benzinga
Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise
July 25, 2024
From Benzinga
Ventura & Associates HTA Advisors Advances Tech-enabled Solution with 3-Year RWD Partnership
July 25, 2024
From PRLog
AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs
July 25, 2024
From Benzinga
AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines
July 25, 2024
From Benzinga
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
July 25, 2024
From Benzinga
Viking Therapeutics Stock Climbs On Q2 EPS Beat
July 24, 2024
From Benzinga
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
July 24, 2024
From Benzinga
From Benzinga
Gilead's $42.5K Priced HIV Drug Could Be Made At Just $40 Annually, Campaigners Urge Company To Slash Price
July 24, 2024
From Benzinga
UK's NHS Prescribes Weight-Loss Drug Wegovy Less Than Expected Due To Service Shortages
July 24, 2024
From Benzinga
From Benzinga
Sage, Biogen Shelve Development Of Nervous System Disorder Drug After Data Disappoints
July 24, 2024
From Benzinga
From Benzinga
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
July 24, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.